AzTrials
AzTrials

Immature Permanent Teeth With Open ApexNCT07123597

Effect of Thickness Variation in Coronal Plug on Root Maturation and Periapical Healing

A study testing 5mm bioceramic putty coronal plug and 3mm bioceramic putty coronal plug in people with Immature Permanent Teeth With Open Apex, run by Rania ElSayed Soliman at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

d. Second visit: After 3 weeks the patients will be randomly divided into 2 groups: Group A: Patients will be anesthetized 1 carpule of mepivacaine without vasoconstrictor (Mepivacaine HCl 3%), the access will be reopened under rubber dam isolation and the canal will be irrigated with a total of 20 ml of 1.5-2.5%… Read more about this study

Who is it for?
Ages 10 to 18 years
Conditions the study is for
Immature Permanent Teeth With Open Apex
What is being tested?
5mm bioceramic putty coronal plug and 3mm bioceramic putty coronal plug
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteEgypt
Study dates
3 Jul 2022to 30 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • All patients were medically free [American Society of Anesthesiologists (ASA) Class I or II].
  • Age ranging between 10-18 years old.
  • No sex predilection.
  • Patients having asymptomatic and/or symptomatic immature necrotic anterior teeth.

Who cannot join

  • Patients with a history of allergy to any of the material used in the study.
  • Patients with systemic diseases (e.g. diabetes mellitus, bleeding disorders, heart diseases, liver diseases, kidney diseases, genetic disorders and syndromes).
  • Psychologically disturbed patients.
  • Teeth that needed a post and core as the final restoration.
  • Patients who had teeth with periodontal pockets more than 3 mm or generalized chronic periodontitis
  • Teeth with developmental anomalies (i.e., dens invaginatus or a palatogingival groove)
  • Patients who had radiographic evidence of external / internal root resorption or cystic lesion.
  • Patients refused participating in the study.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Benha National University

    Cairo, 4470351

Other trials in Egypt

About this study

  1. Second visit:

After 3 weeks the patients will be randomly divided into 2 groups:

Read more

Group A:

Patients will be anesthetized 1 carpule of mepivacaine without vasoconstrictor (Mepivacaine HCl 3%), the access will be reopened under rubber dam isolation and the canal will be irrigated with a total of 20 ml of 1.5-2.5% sodium hypochlorite solution. The canal will then be dried with sterile paper points; a sterile sharp needle will be used to irritate the apical tissue until bleeding occurred apically in the root canal space so as to create a biological scaffold for the regenerative process.

Over a 15-minute time period, the blood will be allowed to clot to a level of 3 mm below the cemento-enamel junction. A resorbable matrix such as CollaPlug™, Collacote™, CollaTape™ will be placed over the blood clot if necessary. Then 3 mm of MTA will be placed using a suitable size amalgam carrier. A damped cotton pellet on a tweezer placed above the unset MTA and large condenser will be used to seal the canal orifice completely. The access cavity will be sealed with Fuji IX glass ionomer filling material and acid etched composite resin bonded filling material.

Group B:

The same procedures that will be followed in group A will be also done in group B, except for the thickness of MTA coronal plug which will be 5mm in its thickness

  1. Follow-up:

The patients will be recalled after 1, 6 and 12 months for follow up. The post-treatment follow-up examination will be accomplished as follows:

  • CBCT scan will be done at 6 and 12 months follow up appointments.
  • An evaluation was performed on each patient to assess presence of any signs and symptoms clinically by inspection, percussion, palpation, or biting on the treated tooth.
Read the detailed description

4.1. Trial Design: The trial design of this study is a prospective, 2-arm, 1:1, parallel, randomized, clinical trial (RCT). In RCT, participants are allocated at random to receive one of several interventions according to the research plan created by the investigators. These interventions may be drug, placebo or certain procedure which is not usually known whether it will be helpful, harmful or with no difference than the available alternatives. In RCT the outcomes are measured, so it is considered a quantitative study. This trial design methodology conforms to the Consolidated Standard of Reporting Trials (CONSORT).

4.2. Participants:

  1. Sample size: Teen participants will be selected from the out patients of the endodontic clinic Faculty of dentistry, Ain Shams University), 9 cases in each group .

4.3. Randomization: Randomization is a process that assigns research participants by chance, rather than by choice, to either the experimental group or the control group. The goal of randomization is to produce comparable groups in terms of general participant characteristics, such as age, gender, chief complain, time pass after trauma, and the other key factors that affect the probable course the disease would take. In this way, the 2 groups are as similar as possible at the start of the study. At the end of the study, if one group has better outcome than the other, the investigators would be able to conclude with some confidence that one intervention is better than the other.

Randomization process was achieved in three steps:

  1. Sequence generation: Sequence generation will be done for the patient's number (from 1 to 10) using computer sequence generation (www.random.org) which will give a table for group A and group B with randomized patient's numbers (5 number in each group).
  2. Allocation concealment mechanism: It is a procedure for protecting the randomization process so that the treatment to be allocated is not known before the patient participated in the study. For the allocation concealment mechanism, each of 10 papers (each paper was eight folded) numbered from 1 to 10 were, individually packed, in opaque envelopes. Each participant picked an envelope at the beginning of the second visit. The number in the envelope determined which procedure will be performed to the patient. The partner will decide the procedure for the operator according to that number.
  3. Implementation:

The random allocation sequence will be done in the Center of The Evidence Based Dentistry, Faculty of Oral and Dental Medicine, Ain Shams University. However, allocation concealment and participant assignment to the intervention will be done by the other investigator.

4.4. Blinding (Masking): Double blinded (Patient and Assessor). Patient will not informed what procedure he/she was subjected to. Assessor will be blinded to the intervention applied on the patient (during pain and swelling assessment).

4.5. Intervention:

Preoperative CBCT scan:

A preoperative CBCT scan will be done to all cases with a high resolution Cone Beam Computed Tomography machine (Planmeca ProMax 3d MID; Planmeca, Helsinki, Finland), with endodontic mode, operating at 90 KV, 12mA with a voxel dimension of 75μm.

In this study 18 patients will be randomly divided into 2 groups (9 patients per each group), where treatment will be completed in 2 visits.

First visit:

A calcium hydroxide intracanal medicament will be utilized in all teeth of both groups.

Second visit:

Group A: Teeth will be treated by regenerative endodontic procedures with placing of 3mm MTA coronal plug .

Group B: Teeth will be treated by regenerative endodontic procedures with placing of 5mm MTA coronal plug.

Being tested
5mm bioceramic putty coronal plug, 3mm bioceramic putty coronal plug
Keywords
regenerative endodontics, root maturation, periapical healing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 5mm bioceramic putty coronal plugOther

    Teeth will be treated by regenerative endodontic procedures with placing of 5mm bioceramic putty coronal plug.

  • 3mm bioceramic putty coronal plugOther

    Teeth will be treated by regenerative endodontic procedures with placing of 3mm bioceramic putty coronal plug.

Study groups in NCT07123597
Study groupRoleWhat they receive
Group AExperimentalGroup A: Teeth will be treated by regenerative endodontic procedures with placing of 5mm coronal plug.
Receives: Other: 5mm bioceramic putty coronal plug
Group BExperimentalGroup B: Teeth will be treated by regenerative endodontic procedures with placing of 3mm coronal plug.
Receives: Other: 3mm bioceramic putty coronal plug

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Root maturation

    after superimposition of the pre and post operative CBCT percentage growth of the root was calculated after

    1. measuring the root length in millimeter in the pre and post operative CBCT increase in length = (follow up length - base line length).
    2. Amount of radiographic increase in the root dentinal wall thickness Dentin thickness in the post operative CBCT = (root thickness-pulp space) and was compared to the baseline CBCT radiograph. The increase in thickness was calculated as follows: increase in thickness = (follow-up thickness -base line thickness).
    3. measuring the decrease of apical diameter: Using the preset measurement scale, the diameter of the apical foramen was measured in millimeters on the 12 months follow up CBCT radiograph and was compared to the baseline CBCT radiograph (decrease of apical diameter = follow-up apical diameter-base line apical diameter).

    Measured: after 12 month

Secondary outcomes (1)
  1. periapical healing

    1. Clinically: By visual inspection of the patient's soft tissue at 1, 3, 6 and 12 months (Swelling). When the case is symptoms-free, i.e., without sinus tract swelling, pain on palpation, or percussions, the case is considered a success.
    2. Radiographically:

    Measuring of the total lesion volume on the 12 months follow up CBCT radiograph and compared to the baseline CBCT radiograph.

    Measured: 12 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2025
  2. Study start3 Jul 2022
  3. Primary completion6 Jun 2023
  4. Study completion30 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07123597
Sponsor's protocol ID
Regenerative Endodontics
Status last verified
Aug 2025
First submitted
7 Aug 2025
Last updated
29 Aug 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: photographs, radiographs, age, sex, general health condition

Questions about this trial

What is this clinical trial studying?

A study testing 5mm bioceramic putty coronal plug and 3mm bioceramic putty coronal plug in people with Immature Permanent Teeth With Open Apex, run by Rania ElSayed Soliman at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Root maturation (time frame: after 12 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in